Exchange Traded Concepts LLC lifted its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 13.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 221,440 shares of the company’s stock after purchasing an additional 26,991 shares during the period. Exchange Traded Concepts LLC’s holdings in Colgate-Palmolive were worth $20,131,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of CL. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $64,000. True Wealth Design LLC grew its position in Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC increased its stake in Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the last quarter. 80.41% of the stock is owned by institutional investors.
Colgate-Palmolive Stock Up 0.5 %
Colgate-Palmolive stock opened at $88.34 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock has a market capitalization of $72.17 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The business has a 50 day simple moving average of $92.00 and a 200-day simple moving average of $97.58. Colgate-Palmolive has a 12 month low of $80.03 and a 12 month high of $109.30.
Colgate-Palmolive Dividend Announcement
Wall Street Analysts Forecast Growth
CL has been the subject of a number of recent research reports. UBS Group dropped their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Barclays cut their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $101.11.
Read Our Latest Stock Report on Colgate-Palmolive
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.34% of the stock is owned by company insiders.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- 5 discounted opportunities for dividend growth investors
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- What is the NASDAQ Stock Exchange?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Calculate Inflation Rate
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.